Clinical Trial Update: A Research Study of a New Medicine NNC0519-0130 in Healthy People, People With High Body Weight and People With Type 2 Diabetes. [Phase 1]

View source ↗

Summary

Phase 1 study of the investigational medicine NNC0519-0130 by Novo Nordisk has completed, enrolling healthy volunteers, overweight individuals, and people with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• NNC0519-0130

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Healthy Volunteers (Diabetes Mellitus, Type 2) | Phase 1 | Status: COMPLETED